March 26 (Reuters) - Zenas Biopharma Inc ZBIO.O:
ZENAS BIOPHARMA ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF CONVERTIBLE SENIOR NOTES DUE 2032 AND COMMON STOCK
ZENAS BIOPHARMA INC - PROCEEDS TO SUPPORT OBEXELIMAB U.S. LAUNCH, PIPELINE ADVANCEMENT, AND GENERAL CORPORATE PURPOSES